RSK
RSK(核糖体S6激酶)
RSK (ribosomal s6 kinase) is a family of protein kinases involved in signal transduction.
RSK 相关产品(32)
- GC10689PF-4708671CAS: 1255517-76-0纯度: >99.50%
PF-4708671 是一种新型的细胞渗透性 S6K1 抑制剂,特异性抑制 S6K1 亚型,Ki 为 20 nM,IC50 为 160 nM。
- GC10918AT7867 dihydrochlorideCAS: 1431697-86-7纯度: >99.00%
A potent and orally bioavailable pan-Akt inhibitor
- GC17407PluripotinCAS: 839707-37-8纯度: >98.50%
A synthetic compound that promotes self-renewal of murine embryonic stem cells
- GC36505LY-2584702 hydrochlorideCAS: 1082948-81-9
LY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. Phase 1.
- GC44095LY2584702 (tosylate)CAS: 1082949-68-5纯度: >99.00%
LY2584702 (tosylate)是一种强效、高选择性的p70 S6激酶的ATP竞争性抑制剂,属于磷脂酰肌醇-3-激酶信号通路的下游组分,IC 50 值为0.004μM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16313 | SL 0101-1 | 77307-50-7 | - | |
A selective inhibitor of RSK | ||||
| GC16779 | BRD 7389 | 376382-11-5 | - | |
An inhibitor of RSKs | ||||
| GC10689 | PF-4708671 | 1255517-76-0 | >99.50% | |
PF-4708671 是一种新型的细胞渗透性 S6K1 抑制剂,特异性抑制 S6K1 亚型,Ki 为 20 nM,IC50 为 160 nM。 | ||||
| GC10918 | AT7867 dihydrochloride | 1431697-86-7 | >99.00% | |
A potent and orally bioavailable pan-Akt inhibitor | ||||
| GC12089 | LY2584702 | 1082949-67-4 | >98.00% | |
A p70S6K inhibitor | ||||
| GC12297 | AT7867 | 857531-00-1 | >98.00% | |
A potent and orally bioavailable pan-Akt inhibitor | ||||
| GC12982 | BIX 02565 | 1311367-27-7 | >99.00% | |
A RSK2 inhibitor with multiple off target effects | ||||
| GC13468 | BI-D1870 | 501437-28-1 | >99.00% | |
An inhibitor of RSK1-4 | ||||
| GC14125 | FMK | 821794-92-7 | >98.00% | |
An inhibitor of RSK2 | ||||
| GC14693 | CMK | 821794-90-5 | >99.50% | |
CMK 是一种 RSK2 激酶抑制剂,与 FMK 相比,具有相似的效力,但化学稳定性较低。 | ||||
| GC15240 | APS-2-79 | 2002381-31-7 | >99.00% | |
An inhibitor of KSR-dependent MAPK signaling | ||||
| GC16039 | LJH685 | 1627710-50-2 | >98.00% | |
An inhibitor of RSKs | ||||
| GC16601 | LJI308 | 1627709-94-7 | >99.00% | |
An inhibitor of RSKs | ||||
| GC17407 | Pluripotin | 839707-37-8 | >98.50% | |
A synthetic compound that promotes self-renewal of murine embryonic stem cells | ||||
| GC17712 | AT13148 | 1056901-62-2 | >99.50% | |
A multi-AGC kinase inhibitor | ||||
| GC32797 | AD80 | 1384071-99-1 | >99.50% | |
AD80, a multikinase inhibitor, shows strong activity against human RET (c-RET), BRAF, S6K, and SRC but were much less active than either AD57 or AD58 against mTOR. The IC50 value for RET is 4 nM. | ||||
| GC34197 | FMK-MEA | 1414811-15-6 | - | |
FMK-MEA 是一种有效的选择性 p90 核糖体 S6 激酶 (RSK) 抑制剂。 | ||||
| GC36505 | LY-2584702 hydrochloride | 1082948-81-9 | - | |
LY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM. Phase 1. | ||||
| GC38755 | CKI-7 | 120615-25-0 | >99.00% | |
A CK1 inhibitor | ||||
| GC38791 | GSK-25 | 874119-56-9 | >99.50% | |
GSK-25 是一种有效的、选择性的,具有口服活性的 ROCK1 抑制剂 (IC50=7 nM)。GSK-25 对 31 种激酶以及 RSK1 和 p70S6K 保持良好的选择性 (RSK1: IC50=398 nM, p70S6K: IC50=1 μM)。GSK-25 可抑制 P450 (CYP2C9、CYP2D6、CYP3A4的IC50 分别为2.5、5.2、2.5 μM)。 | ||||
| GC39715 | M2698 | 1379545-95-5 | >99.50% | |
A dual inhibitor of p70S6K and Akt1 | ||||
| GC43803 | HA-1077 (hydrochloride) | 203911-27-7 | >98.00% | |
A ROCK inhibitor | ||||
| GC44095 | LY2584702 (tosylate) | 1082949-68-5 | >99.00% | |
LY2584702 (tosylate)是一种强效、高选择性的p70 S6激酶的ATP竞争性抑制剂,属于磷脂酰肌醇-3-激酶信号通路的下游组分,IC 50 值为0.004μM。 | ||||
| GC49763 | S6K-18 | 1265789-88-5 | >98.00% | |
A p70S6K1 inhibitor | ||||
